South Korea · Delayed Price · Currency is KRW BIO-FD&C Statistics
Total Valuation
BIO-FD&C has a market cap or net worth of KRW 84.44 billion. The enterprise value is 31.03 billion.
| Market Cap | 84.44B |
| Enterprise Value | 31.03B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BIO-FD&C has 8.70 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 8.70M |
| Shares Outstanding | 8.70M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 31.22% |
| Owned by Institutions (%) | 0.19% |
| Float | 5.19M |
Valuation Ratios
The trailing PE ratio is 13.37.
| PE Ratio | 13.37 |
| Forward PE | n/a |
| PS Ratio | 4.48 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.20 |
| P/FCF Ratio | 14.37 |
| P/OCF Ratio | 12.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.30, with an EV/FCF ratio of 5.28.
| EV / Earnings | 5.01 |
| EV / Sales | 1.65 |
| EV / EBITDA | 4.30 |
| EV / EBIT | 5.31 |
| EV / FCF | 5.28 |
Financial Position
The company has a current ratio of 17.86, with a Debt / Equity ratio of 0.00.
| Current Ratio | 17.86 |
| Quick Ratio | 16.88 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 210.44 |
Financial Efficiency
Return on equity (ROE) is 9.13% and return on invested capital (ROIC) is 27.21%.
| Return on Equity (ROE) | 9.13% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 27.21% |
| Return on Capital Employed (ROCE) | 8.20% |
| Weighted Average Cost of Capital (WACC) | 5.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.95 |
Taxes
In the past 12 months, BIO-FD&C has paid 1.41 billion in taxes.
| Income Tax | 1.41B |
| Effective Tax Rate | 18.59% |
Stock Price Statistics
The stock price has decreased by -45.51% in the last 52 weeks. The beta is 0.29, so BIO-FD&C's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -45.51% |
| 50-Day Moving Average | 13,085.40 |
| 200-Day Moving Average | 15,593.30 |
| Relative Strength Index (RSI) | 19.55 |
| Average Volume (20 Days) | 47,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIO-FD&C had revenue of KRW 18.85 billion and earned 6.20 billion in profits. Earnings per share was 725.98.
| Revenue | 18.85B |
| Gross Profit | 12.52B |
| Operating Income | 5.84B |
| Pretax Income | 7.61B |
| Net Income | 6.20B |
| EBITDA | 7.21B |
| EBIT | 5.84B |
| Earnings Per Share (EPS) | 725.98 |
Balance Sheet
The company has 53.73 billion in cash and 320.02 million in debt, with a net cash position of 53.41 billion or 6,141.80 per share.
| Cash & Cash Equivalents | 53.73B |
| Total Debt | 320.02M |
| Net Cash | 53.41B |
| Net Cash Per Share | 6,141.80 |
| Equity (Book Value) | 70.96B |
| Book Value Per Share | 8,310.02 |
| Working Capital | 56.17B |
Cash Flow
In the last 12 months, operating cash flow was 6.89 billion and capital expenditures -1.01 billion, giving a free cash flow of 5.88 billion.
| Operating Cash Flow | 6.89B |
| Capital Expenditures | -1.01B |
| Depreciation & Amortization | 1.37B |
| Net Borrowing | -1.21B |
| Free Cash Flow | 5.88B |
| FCF Per Share | 675.81 |
Margins
Gross margin is 66.40%, with operating and profit margins of 30.97% and 32.87%.
| Gross Margin | 66.40% |
| Operating Margin | 30.97% |
| Pretax Margin | 40.38% |
| Profit Margin | 32.87% |
| EBITDA Margin | 38.23% |
| EBIT Margin | 30.97% |
| FCF Margin | 31.17% |
Dividends & Yields
BIO-FD&C does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | -0.07% |
| Earnings Yield | 7.34% |
| FCF Yield | 6.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIO-FD&C has an Altman Z-Score of 26.44 and a Piotroski F-Score of 6.
| Altman Z-Score | 26.44 |
| Piotroski F-Score | 6 |